Fidelity International’s iShares Biotechnology ETF IBB Stock Holding History

Fidelity International’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.22M	Sell	6,381 -1,434	-18%	-$246K	﹤0.01%	828
2026 Q1	$1.32M	Sell	7,815 -1,432	-15%	-$245K	﹤0.01%	811
2025 Q4	$1.56M	Sell	9,247 -2,303	-20%	-$374K	﹤0.01%	798
2025 Q3	$1.67M	Sell	11,550 -2,902	-20%	-$396K	﹤0.01%	744
2025 Q2	$1.83M	Sell	14,452 -44	-0.3%	-$5.4K	﹤0.01%	703
2025 Q1	$1.85M	Sell	14,496 -197	-1%	-$26.7K	﹤0.01%	683
2024 Q4	$1.94M	Buy	14,693 +215	+1%	+$30.2K	﹤0.01%	686
2024 Q3	$2.11M	Sell	14,478 -829	-5%	-$120K	﹤0.01%	691
2024 Q2	$2.1M	Sell	15,307 -341	-2%	-$45.5K	﹤0.01%	686
2024 Q1	$2.15M	Buy	+15,648	New	+$2.14M	﹤0.01%	676
2023 Q3	–	Sell	-20,574	Closed	-$2.61M	–	816
2023 Q2	$2.61M	Hold	20,574	–	–	﹤0.01%	620
2023 Q1	$2.66M	Buy	+20,574	New	+$2.69M	﹤0.01%	642

Other funds holding IBB

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Fidelity International's IBB Position: Q2 2026 in Review

Fidelity International reduced its iShares Biotechnology ETF (IBB) stake by 18% in Q2 2026, selling an estimated $246K and leaving 6,381 shares worth $1.22M. The position accounts for ﹤0.01% of the portfolio, ranked #828.

Fidelity International first reported a position in IBB in Q1 2023 and has held it in 12 quarters since. The position peaked at $2.66M in Q1 2023. 889 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Fidelity International held 6,381 shares of iShares Biotechnology ETF worth $1.22M as of Q2 2026.
Fidelity International sold 1,434 iShares Biotechnology ETF shares in Q2 2026, an estimated $246K.
iShares Biotechnology ETF made up ﹤0.01% of Fidelity International's portfolio in Q2 2026, its #828 holding.
Fidelity International first reported a position in iShares Biotechnology ETF in Q1 2023 and has held it in 12 quarters since.
Fidelity International's iShares Biotechnology ETF position peaked at $2.66M in Q1 2023.
889 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Fidelity International's 13F filing for Q2 2026, filed 13 Aug 2026.